Qualcomm’s strategic acquisition of Nuvia for $1.4 billion was meant to bolster its presence in the PC and smartphone markets, positioning the company to rival Apple’s chip performance. However, this move placed Qualcomm in the spotlight of a legal dispute with ARM. ARM has accused Qualcomm of breaching a licensing agreement. Despite this, an eight-member jury in Delaware has been unable to reach a unanimous decision on the matter, signaling a lack of resolution in the licensing controversy.
The presiding Judge, Maryellen Noreika, commented that neither Qualcomm nor ARM emerged with a definitive victory. She has urged both companies to reach a settlement, noting that pursuing another trial could result in unnecessary expenditure of time and resources.
The jury did, however, affirm that Qualcomm’s Snapdragon X Elite and Snapdragon X Plus chipsets, which are key to Qualcomm’s ambitions in the portable computing space, are legitimately licensed under the agreement between Qualcomm and ARM. This ruling allows Qualcomm to continue selling these processors without legal hindrance.
On the other side, ARM has voiced its disappointment regarding the jury’s indecision, maintaining that the protection of its intellectual property remains its primary goal in the dispute.
Qualcomm’s CEO, Christiano Amon, defended the acquisition of Nuvia during the trial, suggesting it could save Qualcomm up to $1.4 billion in licensing fees to ARM. This decision, however, was met with criticism from the company’s board. Among those central to the courtroom debate was Gerard Williams, a former Apple engineer and Nuvia’s founder. Williams testified that Qualcomm’s proprietary cores utilize less than 1% of ARM’s technology.
For now, Qualcomm is continuing its plans uninterrupted, pushing its Snapdragon chipsets into the market. However, with no final resolution in sight, the possibility remains that the conflict with ARM could head back to court in the near future.
